...
首页> 外文期刊>Critical care medicine >Protein and calorie prescription for children and young adults receiving continuous renal replacement therapy: a report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group.
【24h】

Protein and calorie prescription for children and young adults receiving continuous renal replacement therapy: a report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group.

机译:接受连续性肾脏替代治疗的儿童和年轻人的蛋白质和卡路里处方:前瞻性小儿持续性肾脏替代治疗注册小组的报告。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Few published reports describe nutrition provision for critically ill children and young adults with acute kidney injury receiving continuous renal replacement therapy. The goals of this study were to describe feeding practices in pediatric continuous renal replacement therapy and to evaluate factors associated with over- and under-prescription of protein and calories. DESIGN: Retrospective database study. SETTING: Multicenter study in pediatric critical care units. PATIENTS: Patients with acute kidney injury (estimated glomerular filtration rate < 75 mL/min/1.73 m at continuous renal replacement therapy initiation) enrolled in the Prospective Pediatric Continuous Renal Replacement Therapy Registry. INTERVENTIONS: None. MEASUREMENTS: Nutrition variables: initial and maximal protein (g/kg/day) and caloric (kcal/kg/day) prescription and predicted resting energy expenditure (kcal/kg/day). We determined factors predicting initial and maximal protein and caloric prescription by multivariate analysis. RESULTS: One hundred ninety-five patients (median [interquartile range] age = 8.1 [12.8] yrs, 56.9% men) were studied. Mean protein and caloric prescriptions at continuous renal replacement therapy initiation were 1.3 +/- 1.5 g/kg/day (median, 1.0; range, 0-10) and 37 +/- 27 kcal/kg/day (median, 32; range, 0-107). Mean maximal protein and caloric prescriptions during continuous renal replacement therapy were 2.0 +/- 1.5 g/kg/day (median, 1.7; range, 0-12) and 48 +/- 32 kcal/kg/day (median, 43; range, 0-117). Thirty-four percent of patients were initially prescribed < 1 g/kg/day protein; 23% never attained > 1 g/kg/day protein prescription. By continuous renal replacement therapy day 5, median protein prescribed was > 2 g/kg/day. Protein prescription practices differed substantially between medical centers with 5 of 10 centers achieving maximal protein prescription of > 2 g/kg/day in > or = 40% of patients. Caloric prescription exceeded predicted resting energy expenditure by 30%-100%. Factors independently associated with maximal protein and caloric prescription while on continuous renal replacement therapy were younger age, initial protein and caloric prescription and number of continuous renal replacement therapy treatment days (p < 0.05). CONCLUSIONS: Protein prescription in pediatric continuous renal replacement therapy may be inadequate. Inter-center variation exists with respect to nutrition prescription. Feeding practice standardization and research in pediatric acute kidney injury nutrition are essential to begin providing evidence-based feeding recommendations.
机译:目的:很少有公开的报告描述接受持续性肾脏替代治疗的重症儿童和急性肾损伤的年轻成人的营养供应。这项研究的目的是描述小儿连续性肾脏替代治疗中的喂养方法,并评估与蛋白质和卡路里处方过量和处方不足有关的因素。设计:回顾性数据库研究。地点:儿科重症监护室的多中心研究。患者:患有急性肾损伤的患者(估计在连续性肾脏替代治疗开始时肾小球滤过率<75 mL / min / 1.73 m)参加了前瞻性小儿连续性肾脏替代治疗登记册。干预措施:无。测量:营养变量:初始和最大蛋白质(g / kg /天)和热量(kcal / kg /天)处方以及预测的静息能量消耗(kcal / kg /天)。我们通过多变量分析确定了预测初始和最大蛋白质及热量处方的因素。结果:研究了一百九十五名患者(中位[四分位数间距]年龄= 8.1 [12.8]岁,男性占56.9%)。连续肾脏替代治疗开始时的平均蛋白质和热量处方为1.3 +/- 1.5 g / kg /天(中位值1.0;范围0-10)和37 +/- 27 kcal / kg /天(中位值32;范围) ,0-107)。连续肾脏替代治疗期间平均最大蛋白质和热量处方为2.0 +/- 1.5 g / kg /天(中位数1.7;范围0-12)和48 +/- 32 kcal / kg /天(中位数43;范围) ,0-117)。最初有34%的患者开处方的蛋白质<1 g / kg /天; 23%的人从未达到> 1 g / kg / day的蛋白质处方。在第5天连续进行肾脏替代治疗后,处方中位数蛋白质> 2 g / kg /天。各个医疗中心之间的蛋白质处方实践存在很大差异,在10个中心中有5个在>或= 40%的患者中达到最大蛋白质处方> 2 g / kg /天。热量处方超出了预期的静息能量消耗30%-100%。连续肾脏替代疗法时与最大蛋白质和热量处方相关的独立因素是年龄,初始蛋白质和热量处方以及连续肾脏替代疗法治疗天数(p <0.05)。结论:小儿连续性肾脏替代治疗中的蛋白质处方可能不足。营养处方存在中心间差异。小儿急性肾损伤营养的喂养实践标准化和研究对于开始提供循证喂养建议至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号